AshwinNAnanthakrishnanMDMPH

Inflammatory Bowel Disease

Associate Professor of Medicine, Massachusetts General Hospital and Harvard Medical School.

Dr. Ananthakrishnan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Medical College of Wisconsin Affiliated HospitalsFellowship, Gastroenterology, 2007 - 2010
Medical College of Wisconsin Affiliated HospitalsResidency, Internal Medicine, 2004 - 2007
Jawaharlal Institute of Postgraduate Medical Education and ResearchClass of 2003

PubMed

The Ulcerative Colitis-Associated Gene NXPE1 Catalyzes Glycan Modifications on Colonic Mucin.
Ranad Humeidi, Noriko Oshiro-Rapley, Xiebin Gu, Joon Soo An, Ashwin N Ananthakrishnan
Journal of the American Chemical Society. 2025-03-26
Publisher Correction: Microbiota in inflammatory bowel disease: mechanisms of disease and therapeutic opportunities.
Iliyan D Iliev, Ashwin N Ananthakrishnan, Chun-Jun Guo
Nature Reviews. Microbiology. 2025-03-24
Epidemiology, Natural History and Treatment of IBD in Africa: A Scoping Review.
Mmeyeneabasi Omede, Asa Itam-Eyo, Albert Park, Joanah Ikobah, Maryam K Ibrahim
Clinical Gastroenterology and Hepatology. 2025-03-14

Journal Articles

CT-Visualized Colonic Mural Stratification Independently Predicts the Need for Medical or Surgical Rescue Therapy in Hospitalized Ulcerative Colitis Patients
Michael S Gee, Ashwin N Ananthakrishnan, Digestive Diseases and Sciences
Dietary Gluten Intake and Risk of Microscopic Colitis Among US Women Without Celiac Disease: A Prospective Cohort Study
Benjamin Lebwohl, Paul Lochhead, Ashwin N Ananthakrishnan, Andrew T Chan, Kristin E Burke, James M Richter, Hamed Khalili, Nature
Long-Term Outcomes of Immunosuppression-Naïve Steroid Responders Following Hospitalization for Ulcerative Colitis
Jay Luther, Francis Colizzo, Ashwin N Ananthakrishnan, Amar Vedamurthy, John J Garber, Hamed Khalili, Digestive Diseases and Sciences
The Role of Diet in the Aetiopathogenesis of Inflammatory Bowel Disease
Ashwin N. Ananthakrishnan, Hamed Khalili, Nature
Smoking Is Associated with an Increased Risk of Microscopic Colitis: Results from Two Large Prospective Cohort Studies of US Women
Kristin E Burke, Hamed Khalili, Ashwin N Ananthakrishnan, Paul Lochhead, Andrew T Chan, James M Richter, Journal of Crohn's and Colitis
Differences in Clinical Course, Genetics, and the Microbiome Between Familial and Sporadic Inflammatory Bowel Diseases
Hamed Khalili, John J Garber, Ramnik J Xavier, Ashwin N Ananthakrishnan, Vijay Yajnik, Journal of Crohn's and Colitis
Join now to see all

Lectures

Non-Biologic-Based Therapies in IBD
AGC 2018 Annual Scientific Meeting, Philadelphia, PA - 10/7/2018

Does Bezlotoxumab Boost FMT Efficacy in IBD Patients with Recurrent CDI?November 11th, 2024
ACG/ASGE Task Force Identifies 19 Indicators for Achieving Quality GI EndoscopySeptember 11th, 2024
New Guidelines Recommend Stool and Blood Tests to Monitor Ulcerative ColitisFebruary 24th, 2023
Join now to see all

Determinants of inception of inflammation in inflammatory bowel diseasesMASSACHUSETTS GENERAL HOSPITAL2021–2026
Determinants of inception of inflammation in inflammatory bowel diseasesMASSACHUSETTS GENERAL HOSPITAL2021–2026